High Court drugs ruling marks latest skirmish in war of words

The High Court ruling upholding the National Institute for Health and Clinical Excellence's decision over medication for Alzheimer's is just the latest skirmish in what promises to be protracted manoeuvring over drug use and pricing.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here